23 February 2011
Opportunities for Commercialising Drug Discovery in the Academic Sector was held at SCI HQ, London on 17 February 2011, and organised by SCI's Science and Enterprise Group.
Available Conference Papers:
- Programme/Flyer
-
Facilitating partnerships between pharma and academia
Dr Alan Lamont, AstraZeneca -
The Imperial Drug Discovery Centre; enabling translation of academic projects towards commercial reality
Dr Cathy Tralau-Stewart, Imperial Drug Discovery Centre -
Commercialising IP the Oxford way
Ms Linda Naylor, Technology Transfer Group, Oxford University -
Thiakis: from conception to exit
Prof Steve Bloom, Imperial College and Thiakis founder -
The role of public – private partnerships in pharmaceutical R&D
Dr Dave Tapolczay, MRCT
Visit Blog